Outside advisers to the FDA will meet Jan. 12 to review whether the drug should be approved for people with pancreas insufficiency caused by cystic fibrosis, chronic pancreatitis or other conditions.
The Swiss company, which operates its North American business out of Indianapolis, filed a lawsuit late last month against Virginia-based Medical Automation Systems Inc. for breaching the purchase agreement the companies signed back in October.
Observers say conditions are ripening for more deals like the recent $525 million sale of Aprimo Inc. in the months ahead—not only among IT firms, but also among biotech companies here.
The Indianapolis-based drugmaker spent $2.1 million in the three months that ended Sept. 30, a 5-percent increase from the same quarter last year and a jump of more than 30 percent from the $1.6 million it spent in this year's second quarter.
Community Health Network wooed Dr. Robert J. Goulet Jr. to join its breast-surgery team from the Indiana University Simon Cancer Center. The move fits nicely with Community’s focus on breast-care services and the economics of health care.
Mobile medicine has arrived. Decatur County Memorial Hospital in Greensburg became the first hospital in Indiana to start using AirStrip OB, a patient-monitoring system that sends things like the heartbeat waves of patients directly to physicians’ iPhones, BlackBerrys or other mobile devices.
Marcadia Biotech Inc., a Carmel-based biopharmaceutical company founded by prominent scientists from Eli Lilly and Co. in 2006, has been acquired by Swiss life sciences giant Roche.
The suit accused CEO Gary Wendt, President Bill Shea, Chief Financial Officer Charles Chokel and Chief Accounting Officer Jim Adams of engaging in a “massive and systematic coverup of … actual debts and losses through complex accounting, misleading disclosures, and irregular accounting practices.”
State Insurance Commissioner Stephen Robertson said agreements have been reached for the $1.7 billion in policies and financial obligations of Carmel-based Standard Life Insurance Co. to be assumed by Guggenheim Life and Annuity Co.
Two weeks before Manchester College announced a $35 million gift to help open a pharmacy school, a national trade group suggested there are too many pharmacy schools already.
A $250,000 investment in Aarden Pharmaceuticals will go toward advancing tuberculosis therapy through the pre-clinical development stage.
Eli Lilly and Co. and Amylin Pharmaceuticals Inc. said Wednesday they are asking the Food and Drug Administration to expand approval for their type 2 diabetes drug Byetta, which could bolster sales as the companies try to get approval for a new, longer-lasting version of the drug.
Eli Lilly and Co. said the Food and Drug Administration will perform a faster review of florbetapir, an imaging agent that may help diagnose Alzheimer's disease.
The merger of Morgan Hospital & Medical Center into Clarian Health got the go-ahead from all parties in the past week, opening the way for Morgan to bring on new doctors to its facilities.
Zimmer Holdings Inc. completed an acquisition in China on Tuesday, but recession hangovers in the United States and Europe are trumping all other factors and keeping the company’s growth bottled up for now.
WellPoint Inc. and other U.S. health insurers will have to provide justification for any increases to customers’ premiums of more than 10 percent next year, according to federal regulations published Tuesday.
The team, which plans to build an office building in the 200,000-square-foot range, beat out six other groups that submitted proposals.
Indianapolis-based WellPoint Inc. spent $1.1 million lobbying the federal government in the third quarter, as it focused on several issues tied to the health care overhaul Congress passed in March.
Manchester College will use money to launch the state’s third program offering doctorates in pharmacy.
